Financials
- Fiscal year
- 2021
- Turnover
- €164.0m
- Profit
- €4.7m
- Solvency
- 45.3%
Turnover▲ 2.9%
Net result
20182021
CELGENE
InactiveOverview
Activity
Activity not known
Size
€164.0mturnover 2021
- Staff
- 24 FTE
- Equity
- €32.2m
- Profit
- €4.7m
Financial health
Inactive: no score
Structure
- Parent
- Bristol-Myers Squibb Company
0 of 29 deeds read
Signals- Two or more financial years not filedLatest accounts filed on timeShow the evidence
Signals
Two signals.
+raises risk○neutral
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2022, 4 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filingsPosition against the passed deadline
31-12-2022 close31-07-2023 deadline08-10-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2021 was due by 31-07-2022 and was filed on 27-06-2022, 34 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
not filed
2021
34 days early
2020
12 days early
2019
21 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 3 accounts on average 8 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2021 · unclassified…
- Annual accounts filedfiscal year 2020 · unclassified…
- Highest result since 2018net €5.2m ▲23.3%
Key points
By topic
Board & ownership
- Parent
- Bristol-Myers Squibb Company
Timeline
- Events
- 15
- Since
- 2013
- 31-12-2020Equity above €25m
- 21-08-2020Annual accounts filed
- 22-07-2020Board meeting · General meeting
Company details
- Year ends
- 31-12
- Peppol
- Not found in the Peppol directory